Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC

Clinical trial NCT05505175 · COMPLETED

Trial details

NCT number: NCT05505175
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer Breast Carcinoma

Start date: 2022-05-30
Primary completion: 2023-05-02
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.